Enrico Picozza - May 26, 2021 Form 4 Insider Report for DermTech, Inc. (DMTK)

Role
Director
Signature
/s/ Jason S. Miller, attorney-in-fact
Stock symbol
DMTK
Transactions as of
May 26, 2021
Transactions value $
-$813,577
Form type
4
Date filed
5/28/2021, 08:18 PM
Previous filing
May 25, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DMTK Common Stock Award $0 +4.5K +32.12% $0.00 18.5K May 26, 2021 Direct F1
transaction DMTK Common Stock Award $0 +4.66K +25.2% $0.00 23.2K May 26, 2021 Direct F2
transaction DMTK Common Stock Sale -$814K -20.3K -3.9% $40.08* 500K May 26, 2021 By HLM Venture Partners IV, L.P. F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest in four equal quarterly installments over the one-year period following the grant date, subject to the reporting person's continued service. The shares underlying any vested restricted stock units shall be released to the reporting person on May 26, 2022.
F2 The securities awarded are in the form of restricted stock units issued pursuant to the issuer's 2020 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of issuer common stock. The restricted stock units shall vest, and the shares underlying the restricted stock units shall be released to the reporting person, on January 1, 2023, subject to the reporting person's continued service.
F3 This transaction was executed in multiple trades at prices ranging from $40.00 to $40.32, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) of this Form 4.
F4 The reporting person has a pecuniary interest in HLM Venture Associates IV, LLC ("HLM GP"). HLM GP is the general partner of HLM Venture Partners IV, L.P., which owns the reported securities. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.